Chu Yujin, Gao Yakun, Tang Wei, Qiang Le, Han Yingkuan, Gao Jianwei, Zhang Yu, Liu Hong, Han Lin
Institute of Marine Science and Technology, Shandong University, Qingdao, Shandong 266237, China.
School of Basic Medical Science, Shandong University, Jinan, Shandong 250100, China.
Anal Chem. 2021 Mar 30;93(12):5129-5136. doi: 10.1021/acs.analchem.0c04896. Epub 2021 Mar 15.
Non-invasive early diagnosis is of great significance in disease pathologic development and subsequent medical treatments, and microRNA (miRNA) detection has attracted critical attention in early cancer screening and diagnosis. High-throughput, sensitive, economic, and fast miRNA sensing platforms are necessary to realize the low-concentration miRNA detection in clinical diagnosis and biological studies. Here, we developed an attomolar-level ultrasensitive, rapid, and multiple-miRNA simultaneous detection platform enabled by nanomaterial locally assembled microfluidic biochips. This platform presents a large linear detection regime of 1 aM-10 nM, an ultralow detection limit of 0.146 aM with no amplification, a short detection time of 35 min with multiplex miRNA sensing capability, and a small sample volume consumption of 2 μL. The detection results of five miRNAs in real samples from breast cancer patients and healthy humans indicate its excellent capacity for practical applications in early cancer diagnosis. The proposed ultrasensitive, rapid, and multiple-miRNA detection microfluidic biochip platform is a universal miRNA detection approach and an important and valuable tool in early cancer screening and diagnosis as well as biological studies.
非侵入性早期诊断在疾病病理发展及后续治疗中具有重要意义,而微小RNA(miRNA)检测在早期癌症筛查与诊断中备受关注。为实现临床诊断和生物学研究中低浓度miRNA的检测,需要高通量、灵敏、经济且快速的miRNA传感平台。在此,我们开发了一种由纳米材料局部组装微流控生物芯片实现的阿托摩尔级超灵敏、快速且能同时检测多种miRNA的平台。该平台具有1 aM至10 nM的大线性检测范围,无扩增时超低检测限为0.146 aM,具有多重miRNA传感能力的短检测时间为35分钟,且样品消耗量小至2 μL。来自乳腺癌患者和健康人的实际样本中五种miRNA的检测结果表明其在早期癌症诊断中的实际应用能力出色。所提出的超灵敏、快速且能同时检测多种miRNA的微流控生物芯片平台是一种通用的miRNA检测方法,也是早期癌症筛查与诊断以及生物学研究中的重要且有价值的工具。